Bristol Myers cell therapy manufacturing site gets thumbs-up from FDA
A new Bristol Myers Squibb cell manufacturing site that is expected to make the CAR-T therapy Breyanzi has received FDA approval to start production. …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
